Veradermics Reports Positive Phase 3 VDPHL01 Topline Results
Veradermics said VDPHL01 produced hair-count increases of up to 36.4 hairs/cm², with no treatment-related serious adverse events.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.